Mehta Sanjay 4
4 · TERADYNE, INC · Filed May 7, 2024
Insider Transaction Report
Form 4
Mehta Sanjay
VP and Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-05-03$72.10/sh+3,750$270,375→ 45,652.345 total - Sale
Common Stock
2024-05-03$120.06/sh−3,750$450,225→ 41,902.345 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-03−3,750→ 0 totalExercise: $72.10Exp: 2027-01-24→ Common Stock (3,750 underlying)
Footnotes (2)
- [F1]The reported transactions were effected pursuant to a sales plan adopted by the Reporting Person on May 12, 2023 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- [F2]This option was granted under the Issuer's 2006 Equity and Cash Compensation Incentive Plan, and became exercisable at the rate of 25% per year commencing on January 24, 2021, the first anniversary of the grant.